Tissue Procurement for Biomedical Research - Tabular View

Tracking Information

First Received Date ^ICMJE

September 12, 2005

Last Updated Date

May 28, 2009

Start Date ^ICMJE

February 2003

Estimated Primary Completion Date

December 2012 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00182858 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Tissue Procurement for Biomedical Research

Official Title ^ICMJE

Tissue Procurement

Brief Summary

The purpose of this study is to obtain human tissue samples for scientific study.

Detailed Description

Researchers frequently need tissue samples (blood, urine, saliva, sweat, or other body fluid/tissue) to help them understand more about a particular disease or process. This protocol is designed to create the opportunity to obtain such samples that would otherwise be discarded during the course of usual clinical care, or alternatively to obtain such samples during patient screening for other studies.

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Cohort, Prospective

Condition ^ICMJE

Cardiovascular Diseases
Cancer
Endocrine Diseases
Neurological Disorders
Arthritis
Mental Disorders

Intervention ^ICMJE

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Estimated Enrollment ^ICMJE

5000

Estimated Completion Date

December 2012

Estimated Primary Completion Date

December 2012 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

18 years of age or older
Identified by the investigator to have a condition of interest (cardiovascular disease, cancer, endocrine disease, neurological disease, arthritis, psychiatric disease) for exploratory studies related to the patient's illness or other feature that offers the possibility of generation of hypotheses for future studies

Exclusion Criteria:

Unwilling to be subjected to diagnostic and/or therapeutic procedures that are not necessary for clinical management
Excessive blood loss in this study plus other research participation and/or clinical evaluation that will result in blood loss of greater than 1 unit (400ml or 1 pint) over an 8 week period
Inability to give informed consent

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact: NIA Recruiter

410-350-3941

NIAStudiesRecruitment@mail.nih.gov

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00182858

Responsible Party

William B. Ershler, MD, Principle Investigator, Clinical Research Branch, National Institute of Aging

Study ID Numbers ^ICMJE

AG0039

Study Sponsor ^ICMJE

National Institute on Aging (NIA)

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

William B. Ershler, MD

National Institute on Aging, Laboratory of Clinical Investigation

Information Provided By

National Institute on Aging (NIA)

Verification Date

May 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP